Stephens Cuts Encompass Health (NYSE:EHC) Price Target to $74.00

Encompass Health (NYSE:EHCGet Rating) had its price objective cut by Stephens from $78.00 to $74.00 in a report published on Tuesday, The Fly reports. They currently have an overweight rating on the stock.

A number of other equities research analysts also recently weighed in on the stock. Royal Bank of Canada dropped their price target on shares of Encompass Health from $85.00 to $82.00 in a research note on Wednesday, June 8th. Truist Financial upped their target price on shares of Encompass Health from $78.00 to $85.00 in a research note on Thursday, April 7th. TheStreet raised shares of Encompass Health from a c+ rating to a b- rating in a research note on Tuesday, March 15th. StockNews.com downgraded shares of Encompass Health from a buy rating to a hold rating in a research report on Friday, June 10th. Finally, Raymond James lowered their price objective on shares of Encompass Health from $85.00 to $70.00 in a research report on Friday, June 17th. One research analyst has rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of Buy and an average price target of $79.56.

EHC opened at $54.72 on Tuesday. The company has a debt-to-equity ratio of 1.32, a current ratio of 1.26 and a quick ratio of 1.26. The company has a market cap of $5.46 billion, a price-to-earnings ratio of 13.99, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The firm has a 50 day simple moving average of $63.87 and a 200 day simple moving average of $65.26. Encompass Health has a fifty-two week low of $53.03 and a fifty-two week high of $85.75.

Encompass Health (NYSE:EHCGet Rating) last posted its quarterly earnings results on Wednesday, April 27th. The company reported $0.97 earnings per share for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The business had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.32 billion. Encompass Health had a net margin of 7.51% and a return on equity of 17.99%. Encompass Health’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.05 earnings per share. As a group, analysts expect that Encompass Health will post 4.09 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 20th. Investors of record on Wednesday, July 13th will be issued a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a yield of 2.05%. The ex-dividend date of this dividend is Tuesday, July 12th. Encompass Health’s payout ratio is 28.64%.

In other Encompass Health news, Director Kevin J. O’connor bought 1,000 shares of Encompass Health stock in a transaction that occurred on Friday, May 6th. The stock was acquired at an average price of $66.48 per share, for a total transaction of $66,480.00. Following the completion of the acquisition, the director now owns 3,436 shares of the company’s stock, valued at approximately $228,425.28. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 2.70% of the company’s stock.

A number of hedge funds have recently made changes to their positions in the business. Personal CFO Solutions LLC lifted its stake in Encompass Health by 4.2% in the third quarter. Personal CFO Solutions LLC now owns 4,101 shares of the company’s stock valued at $308,000 after acquiring an additional 167 shares during the last quarter. Bank of Montreal Can lifted its stake in Encompass Health by 1.5% in the first quarter. Bank of Montreal Can now owns 11,340 shares of the company’s stock valued at $806,000 after acquiring an additional 173 shares during the last quarter. Signaturefd LLC lifted its stake in Encompass Health by 58.9% in the fourth quarter. Signaturefd LLC now owns 499 shares of the company’s stock valued at $33,000 after acquiring an additional 185 shares during the last quarter. BNP Paribas Arbitrage SA lifted its stake in Encompass Health by 1.5% in the third quarter. BNP Paribas Arbitrage SA now owns 13,145 shares of the company’s stock valued at $986,000 after acquiring an additional 189 shares during the last quarter. Finally, Louisiana State Employees Retirement System lifted its stake in Encompass Health by 0.8% in the fourth quarter. Louisiana State Employees Retirement System now owns 25,600 shares of the company’s stock valued at $1,671,000 after acquiring an additional 200 shares during the last quarter. Hedge funds and other institutional investors own 91.70% of the company’s stock.

About Encompass Health (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading

The Fly logo

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.